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Abstract
Background: DNA epigenetic modifications, such as methylation, are important regulators of tissue differentiation,
contributing to processes of both development and cancer. Profiling the tissue-specific DNA methylome patterns
will provide novel insights into normal and pathogenic mechanisms, as well as help in future epigenetic therapies.
In this study, 17 somatic tissues from four autopsied humans were subjected to functional genome analysis using
the Illumina Infinium HumanMethylation450 BeadChip, covering 486 428 CpG sites.
Results: Only 2% of the CpGs analyzed are hypermethylated in all 17 tissue specimens; these permanently methylated
CpG sites are located predominantly in gene-body regions. In contrast, 15% of the CpGs are hypomethylated in all
specimens and are primarily located in regions proximal to transcription start sites. A vast number of tissue-specific
differentially methylated regions are identified and considered likely mediators of tissue-specific gene regulatory mechanisms
since the hypomethylated regions are closely related to known functions of the corresponding tissue. Finally, a clear inverse
correlation is observed between promoter methylation within CpG islands and gene expression data obtained from publicly
available databases.
Conclusions: This genome-wide methylation profiling study identified tissue-specific differentially methylated regions in 17
human somatic tissues. Many of the genes corresponding to these differentially methylated regions contribute to tissue-
specific functions. Future studies may use these data as a reference to identify markers of perturbed differentiation and
disease-related pathogenic mechanisms.
Background
DNA methylation is the most extensively studied epigenetic
modification of mammalian DNA [1]. DNA methylation of
cytosine residues mainly occurs in CpG sequences and has
been characterized as an important regulatory mechanism
of genome function, having been implicated as a crucial me-
diator of embryonic development, transcription, chromo-
somal stability, imprinting, and X-chromosome inactivation
[2]. The DNA methylation profile itself is not static and sub-
ject to dynamic changes induced by age-related factors [3],
environmental factors [4], nutritional factors, and patho-
genic factors, such as viruses [5,6].
Many previous studies have investigated the DNA methy-
lation profiles of various human tissues and conditions.
These studies have mainly relied on high-throughput DNA
detection methods and sequencing technologies, such as
the HumanMethylation450 BeadChip [7], HumanMethyla-
tion27 BeadChip [8] and GoldenGate Methylation Cancer
Panel I [9-11] arrays (Illumina Inc., San Diego, CA, USA),
or microarrays in combination with methylated DNA en-
richment by immunoprecipitation [12]. Some previous
studies have concentrated on CpG islands in promoter re-
gions and characterized for their role in changes to the
gene’s expression [8,10], but increasingly more studies are
identifying tissue-specific differentially methylated regions
(tDMRs) in the gene body regions [12,13]. Although all the
previous studies have enabled a broader view of the
genome-wide DNA methylation patterns, there still remain
questions to be answered, for example, how the tDMRs are
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being established and what are the functions of gene-body
tDMRs. Determining the human tDMR profile will not only
provide important insights into the normal processes of
tissue-specific differentiation but may identify markers of
pathogenic processes, such as cancer.
In this study, we analyzed the tissue-specific DNA
methylome using a panel of 17 somatic tissues obtained
from four autopsied individuals. The expanded Illumina
Infinium HumanMethylation450 BeadChip was used to
interrogate 486 428 CpG sites in the human genome;
this advanced platform boasts unbiased coverage of gene
and CpG island (CGI) regions reaching up to 99% and
96%, respectively, as well as CpG island shores (2 kb re-
gions upstream and downstream of the CpG islands)
and shelves (2 kb regions upstream and downstream of
the CpG island shores) to reveal a genome-wide methy-
lation profile [14].
Our aim was to describe the general patterns of glo-
bally conserved and tissue-specific DNA methylation
with functional consequences in gene regulation. Using
the high-density microarray allowed nearby CpG sites
with similar patterns to be grouped together so as to
identify broader regions of tDMRs and improve the stat-
istical power of the analysis. Our results reveal tissue-
specific methylation patterns beyond the well-studied
promoter areas, identifying tDMRs in gene body areas
and showing these regions to be more likely related to
tissue-specific functions. Collectively, these data repre-
sent novel insight into the regulatory role of tissue-
specific DNA methylation.
Results and discussion
Methylome profiling across 17 somatic tissues
Tissue-specific DNA methylation patterns were studied
in the following 17 somatic tissues: abdominal and sub-
cutaneous adipose tissue, bone, joint cartilage, yellow
and red bone marrow, coronary and splenic artery, ab-
dominal and thoracic aorta, gastric mucosa, lymph node,
tonsils, bladder, gall bladder, medulla oblongata, and
ischiatic nerve. Samples of each of these postmortem
specimens were obtained from four individuals upon
autopsy, except in the case of one individual (Identifica-
tion No. BM419/4) for whom the yellow bone marrow
and joint cartilage tissues were not available. The causes
of death included: intracerebral hemorrhage (BM419/4; fe-
male, 60 years old), heart attack with acute cardiac insuffi-
ciency (KA522; male, 53 years old), heart attack (KT538;
male, 40 years old), and intracerebral hemorrhage (SJ600-
5; male, 54 years old).
Genomic DNA was extracted from each tissue, treated
with sodium bisulfite, and subjected to analysis via the
Illumina Infinium HumanMethylation450 BeadChip. The
methylation levels of CpGs were described as beta values
(0 to 1) representing the calculated level of methylation
(0% to 100%). We had two technical and two biological
replicates processed by chip technique. The Pearson cor-
relation coefficients (PCCs) were >0.99 for all the repli-
cates, confirming a good level of reproducibility for the
chip process and indicating that the observed differential
methylation between the studied tissues represented true
biological differences.
Several of the observed DNA methylation differences
were selected for verification by conventional Sanger
dideoxy sequencing. More specifically, the detected CpG
methylation levels of 17 genes encompassing 36 CpGs,
including 0% (n = 1) and 100% (n = 2) methylated sites,
and of 14 genes with tDMRs, were confirmed by bisulfite
sequencing. The BeadChip data strongly correlated with
the Sanger sequencing data (mean PCC: 0.93, PCC
range: 0.78 to 0.98; Additional file 1). Methylation levels
of CpGs adjacent to those present on the BeadChip were
also strongly correlated with the Sanger sequencing data
(mean PCC 0.95, PCC range: 0.72 to 1.00). Most of the
CpGs detected were clustered together, but some CpGs
with similar methylation levels and corresponding to a
known gene or regulatory region were located >200 bp
apart (data not shown). Thus, uniform CpG methylation
may involve longer distances for tissue-specific regula-
tory mechanisms.
Comparative analysis of the DNA methylation patterns
between tissues was carried out to determine a general
relatedness profile. The methylation patterns were found
to be well conserved between the 17 various tissues that
were studied (Figure 1). The lowest correlations were
found for red bone marrow versus thoracic and splenic
artery, versus bladder, and versus medulla oblongata and
ischiatic nerve (PCC: 0.93). The highest correlations
were found among functionally similar tissues, such as
the different arteries and aortas, red and yellow bone
marrow, and bone and joint cartilage (PCC: ≥0.99). Hier-
archical clustering of the methylation profiles of the 17
studied tissues showed that most of the similar tissues
(for example, aortas and arteries) co-clustered (Figure 2);
the strong correlations indicated between similar tissues
suggested the presence of tissue-specific methylation
profiles.
Genome-wide DNA methylation patterns
Investigation of the global distribution of CpGs in somatic
tissues according to the methylation status revealed that a
large portion of the detected CpGs are either unmethy-
lated (0%) or fully methylated (100%) (Additional file 2).
Considering the collected data for all 17 tissues indicated
that only 2.2% of all the CpGs (10,707 CpGs representing
4,416 genes) were hypermethylated in all of the samples
(beta values >0.9). These invariably methylated CpGs were
mostly located in gene bodies, in the 3’-untranslated re-
gions (UTRs) (66.8%, 7,150 CpGs; Figure 3) or in non-
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CGIs (77.4%, 8,287 CpGs; Figure 4A) (Fisher’s exact test,
P <2.2 × 10-16). Thus, DNA methylation appears to be more
prominent in the areas where CpG density is low and tran-
scription is not usually initiated.
On the other hand, 14.9% of CpGs (72,444 CpGs
representing 12,604 genes) were hypomethylated in all
of the samples (beta values <0.1). These invariably hypo-
methylated CpGs were mostly located in gene promoter
areas (73.2%, 53,057 CpGs), including the sequence re-
gion from -200 to -1,500 nt upstream of the transcrip-
tion start site (TSS1500), the region from -200 nt
upstream to the TSS itself (TSS200), and the region
from the 5’-UTR through the first exon (Figure 3). In
addition, the hypomethylated CpGs were found in CGI
regions (73.0%, 52,862 CpGs; Figure 4A) (Fisher’s exact
test, P <2.2 × 10-16). These findings are consistent with the
general consensus that gene promoter areas and CGI re-
gions of actively transcribed genes are largely unmethy-
lated so as to be accessible to transcription factors.
Gene ontology (GO) analysis with the Database for
Annotation, Visualization and Integrated Discovery (DA-
VID [15]) revealed that many of the genes showing
hypermethylation of their CGI-promoter regions had
functions related to the reproductive system; in contrast,
many of the genes showing hypomethylation of their
CGI-promoter regions had functions associated with
housekeeping processes, including RNA processing and
cell cycle. When our data of hypomethylated CGI-
promoter regions were compared to the housekeeping
genes identified by expression profiling in a previous
study by Chang et al. [16], we found a 93.0% consensus.
We also found that the DNA methylation pattern of a
single gene varies between gene regions; for example,
compared to the gene body, the TSS1500, TSS200, 5’-
UTR, and first exon showed lower average methylation
(Figure 3). These data agree with those from previous
studies and in line with the notion that promoter areas of
housekeeping genes would be accessible to support active
transcription [17].
Comparison of DNA methylation in CGI and non-island
regions
It is well recognized that DNA methylation patterns can
differ significantly across the different regions of CGIs,
with methylation levels increasing at the boundaries. In






















































































































Figure 1 Correlation of methylation intensities between tissues. The mean methylation levels of each CpG site within different specimens of
the same tissue were compared and the PCC was calculated. The correlation matrix of different tissues is shown; the tissues appear to show a
similar trend, for which the highest correlations occur between functionally similar tissues.
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in the CGI shelves and shores (Figure 4A). These results
are in agreement with those of previous studies [17,18],
in which the majority of CGIs were shown to be
unmethylated. Also, in our study, the CGI methylation
patterns were found to be largely consistent within inter-
genic regions and in genes (Figure 4B and 4C). It is pos-
sible that maintaining an unmethylated state in a CGI
may serve to protect against mutation by spontaneous
deamination of methylated cytosines [19].
Comparison of CGI methylation patterns across differ-
ent parts of individual genes revealed that the promoter
areas (TSS1500, TSS200, and 5’-UTR) and the first exon
were almost exclusively unmethylated; however, variable
CGI methylation levels were found in the gene body and
3’-UTR (Figure 5A). This pattern has been observed by
other studies, as well [12,18]. In contrast, the CpGs
found in non-CGI regions were found to be mostly
methylated, and showed little variation across the differ-
ent parts of the individual genes (Figure 5B). Compara-
tive analysis of the methylation patterns in CGI shores
and shelves in different gene regions revealed that the
CGI and CGI shore regions are generally similar, but the
CpGs in the shelves are nearly fully methylated (data not
shown).
Tissue-specific differentially methylated regions
Next, the regions with distinctive methylation patterns in
certain tissues were analyzed in detail. We applied an algo-
rithm to identify statistically significant differential methy-
lation existing between two sets of samples in three or
more consecutive CpG probes. This new method is based
on fitting ANOVA models in moving windows of different
lengths, encompassing up to 50 probes. The optimal re-
gion boundaries were selected according to the minimum
description length (MDL) principle. As a result, every re-
gion consists of probes that have similar methylation pat-
terns. As HumanMethylation450 BeadChip is focused
more on the genes and promoter areas, this robust ap-
proach finds more likely regions with a higher CpG probe
density.
We used this method to detect tDMRs between one
tissue of interest and all other tissues under study. For
this analysis, the data from some of the tissues used in




















Figure 2 Hierarchical clustering of the 17 tissues studied. Hierarchical clustering analysis was performed using the hclust command in R. All
of the samples were merged according to their corresponding tissues, which resulted in a matrix of the mean beta values for all of the CpG sites
detected in the 17 total tissues. The clustering tree was generated using the complete method. The tree shows strong correlation between
similar tissue types.
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Figure 3 DNA methylation in specific gene regions. Distribution of DNA methylation in specific gene regions is shown. Each gene region is
further divided into bins that correspond to beta values with 0.1 intervals. The area of each bin corresponds to total number of CpGs. The overall
distribution and the mean of beta value of the CpGs in each gene region are shown as a box plot. The most unmethylated regions are associated with
promoter sequences (TSS1500, TSS200, and 5′-UTR) and the first exon, while the most methylated regions are in the gene body and 3′-UTR. The numbers
on the x-axis correspond to total number of CpGs in each gene region; also the x-axis shows different gene regions, and the y-axis shows the beta values.
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Figure 4 CGI methylation in different genomic regions. Distribution of DNA methylation in specific gene regions is shown. Each gene region
is further divided into bins that correspond to beta values with 0.1 intervals. The area of each bin corresponds to total number of CpGs. The
overall distribution and the mean of beta value of the CpGs in each gene region are shown as a box plot. (A) The distribution of DNA methylation in
CGI and non-CGI regions shows that the CGI itself is largely unmethylated and that the shores and shelves are methylated. (B, C) The distribution of
CGI and non-CGI DNA methylation in intergenic (B) and intragenic (C) regions. (A-C) The numbers on the x-axis correspond to total number of CpGs
in each gene region; also the x-axis shows different genomic regions, and the y-axis shows the beta values.
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functional similarity that existed between them; specific-
ally, abdominal and subcutaneous adipose tissues were
processed together, as were the thoracic and abdominal
aorta, coronary and splenic artery, joint cartilage and
bone, and red and yellow bone marrow.
The numbers of different tDMR CpG blocks were found
to vary greatly between tissues with different functions
(Table 1). The highest number of hypermethylated tDMRs
was found in tonsils, followed by medulla oblongata and
aortas (abdominal and thoracic). The lowest number of
hypermethylated tDMRs was found in lymph nodes. For
hypomethylated tDMRs, large numbers were found in bone
marrow (red and yellow), aortas (abdominal and thoracic),
and ischiatic nerve, while the lowest number was found in
the lymph nodes. Of the total 14,441 tDMRs identified
(Additional file 3), 11,242 (77.8%) mapped to genes. Among
those, 41.7% (4,688) were in gene promoter areas with only
36.5% in CGIs (Fisher’s exact test, P <2.2 × 10-16), and more
than one-half (58.3%, 6,554) in gene body regions with
44.1% in CGIs (Fisher’s exact test, P <2.2 × 10-16). The fact
that over a half of tDMRs were located in gene bodies and
not in promoter areas is intriguing because methylation
within a gene body may indicate the presence of alterna-
tive promoters [20]. Among the intergenic tDMRs, 45.8%
co-localized with CGIs (Fisher’s exact test, P = 0.0003),
intergenic regions might act as regulators, being either en-
hancers or silencers and contributing with these mecha-
nisms into maintenance of tissue-specific gene expression.
These results are in line with those of previous studies,
which have shown that tDMRs exist across a range of CpG
densities, while tDMRs in promoter areas are largely lo-
cated in non-CGI regions [7,11,12,18].
In order to study which regions are the most variable
between tissues, we compared the proportion of vari-
ance explained by the tissues between different gene re-
gions and between CpG islands, shores, and shelves.
Additional file 4A and B show the distributions of the R
squared statistic, respectively. We can see that in gene
body, 3’-UTR and the sites that are not related to genes,
exist larger differences between the tissues. But in the
gene promoter areas the methylation patterns of tissues
are much more similar. This is supported also from the
results above, that large number of tDMRs were found
within gene body regions. Also, in CpG islands different
tissues are more similar than in shores, shelves, and
non-island sites.
To characterize the function of genes related to the
detected tDMRs, we again performed GO analysis using
the DAVID database. We have used a custom back-
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Figure 5 DNA methylation distribution in CGI and non-CGI regions. Distribution of DNA methylation in specific gene regions is shown. Each
gene region is further divided into bins that correspond to beta values with 0.1 intervals. The area of each bin corresponds to total number of
CpGs. The overall distribution and the mean of beta value of the CpGs in each gene region are shown as a box plot. (A) DNA methylation is low
in promoter areas, but high in non-CGI regions of all gene areas (B). (A-B) The numbers on the x-axis correspond to total number of CpGs in
each gene region; also the x-axis shows different genomic regions, and the y-axis shows the beta values.
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all the genes that were found as tDMRs. This should
take in account the distribution of CpG probes on
microarray. As shown in Table 2, those genes showing
hypomethylation in certain tissues are frequently associ-
ated with a tissue-specific function. For example, the
hypomethylated genes detected in arteries (including
COL18A1, EPAS1, ENPEP, ANGPT2, and APOLD1) are
characterized as mediators of blood vessel development
and morphogenesis, while those detected in tonsils (in-
cluding LAX1, TNFSF14, LCK, and RHOH) are involved
in immune response and leukocyte activation.
In agreement with previous results, none of the genes
showing hypermethylation in specific tissues were associ-
ated with tissue-specific biological processes (Additional
file 5) [8]. Thus, our results, along with those from earlier
studies, strongly support the hypothesis that hypomethyla-
tion, and not hypermethylation of genes, is more likely to
be associated with the tissue-specific functions.
Inter-individual methylation variation
We analyzed the rate of inter-individual variation in
order to understand whether individuals or tissues are
explaining most of the variability between samples. We
compared the proportion of variance of the beta values ex-
plained by the individuals and the proportion of variance ex-
plained by the tissues. Figure 6 shows the distribution of the
R squared statistic obtained for each CpG site. On average,
we can see that individuals explain only 6.4% of the variance
whereas tissues explain 51.2%, showing that although the
variance between individuals exist, it is really insignificant.
The hierarchical clustering (Additional file 6) of all the
samples studied is also showing that the similarity be-
tween different tissues was higher than between individ-
uals, as tissues are mostly clustering together. As the
number of individuals under investigation was relatively
small (n = 4; one woman and three men) and also the
majority of the phenotypic data was lacking, we did not
find relevant to analyse the inter-individual methylation
variation in detail. Furthermore, it is explaining only
subset of variance between samples.
Relation between gene expression and global DNA
methylation
To further investigate the role of DNA methylation in regu-
lation of gene expression, we compared the detected
methylation patterns with publicly available gene expression
data (Gene Expression Omnibus (GEO) and ArrayExpress
databases). Only tissues with gene expression data obtained
using a single platform (Human Genome U133A arrays;
Affymetrix, Santa Clara, CA, USA) were selected to de-
crease the impact of potential confounding factors. As a re-
sult, correlations of gene expression levels were carried out
for eight of the 17 tissues used in the original analysis:
aorta, bladder, bone, bone marrow, coronary artery, lymph
node, medulla oblongata, and tonsils (Additional file 7).
The method by which the global methylation data
were correlated with the gene expression data relied on
averaging beta values across the comprehensive gene
panel. The PCCs were calculated for 10,120 genes across
the eight tissues (Table 3) and revealed a slight bias to-
wards negatively-correlated genes’ expression (5,710 vs.
positively-correlated: 4,410 genes). In addition, nearly
twice as many genes showed a strong inverse correlation
(1,713 genes, PCCs: <-0.5) than those showing a strong
positive correlation (1,090 genes, PCCs: >0.5) (Fisher’s
exact test, P <2.2 × 10-16).
When analyzing the correlation of global methylation data
with different gene regions, the number of negatively-
correlated genes in CGI-promoter areas (56.7%) was found
to be roughly the same as that in gene bodies (52.7%).
Slightly more genes showed a strong inverse correlation
than those showing a strong positive correlation, both for









Adipose (subcutaneous, abdominal) 84 65 376 301
Artery (coronary, splenic) 380 280 283 219
Bone, joint cartilage 129 73 168 104
Bone marrow (red, yellow) 175 150 1,300 1,028
Gastric mucosa 74 54 26 22
Lymph node 56 42 5 3
Tonsils 4,983 3,893 1,072 924
Bladder 379 274 752 566
Gall bladder 65 47 93 66
Aorta (thoracic, abdominal) 628 453 1120 888
Medulla oblongata 651 495 349 278
Ischiatic nerve 203 156 1,090 861
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methylation located within the promoter area and the gene
body (11.5% and 10.6% in promoter-CGI; 16.1% and 12.1%
in gene body, respectively) (Fisher’s exact test, P= 0.005).
When DNA methylation and gene expression values
are similar among a set of various tissues, correlation
analysis may be insufficient. To correct for this possibil-
ity in our dataset, the methylation and gene expression
data were plotted onto a single figure so that the integ-
rity of the correlation between CGI-promoter and gene
body areas could be further assessed (Figure 7). In the
CGI-promoter areas, high levels of methylation were
found to be associated with lower gene expression and
low levels of methylation were associated with higher,
and varying, levels of gene expression. However, the
same relationship was not observed for the data related
to gene bodies; the fully methylated and unmethylated
genes showed a similar varying trend in their gene ex-
pression levels.
Our analysis of highly methylated promoters suggested
a possible link between the promoter methylation and
suppressed gene expression. Similar to our findings, pre-
vious studies have reported that genes with unmethy-
lated promoters show variable levels of transcription
activity [12,18]. Our analysis of methylation in gene
Table 2 GO analysis with hypomethylated tDMRs
Tissue GO term Genes (n) P value
Adipose tissue (abdominal, subcutaneous) Lipid homeostasis 5 0.0096
White fat cell differentiation 3 0.0172
Fat cell differentiation 4 0.0532
Artery (coronary, splenic) Blood vessel morphogenesis 12 3.24E-04
Angiogenesis 10 4.25E-04
Blood vessel development 13 4.60E-04
Aorta (thoracic, abdominal) Cardiac muscle tissue development 11 5.91E-04
Muscle organ development 24 8.21E-04
Striated muscle tissue development 16 9.72E-04
Bone, joint cartilage Chondrocyte differentiation 3 0.0067
Cartilage development 4 0.0253
Skeletal system development 7 0.0553
Bone marrow (red, yellow) Cell activation 41 5.07E-07
Leukocyte activation 33 7.98E-06
Immune response 62 1.97E-05
Lymph node -
Tonsils Immune response 59 7.00E-06
Regulation of T cell activation 17 4.38E-05
Defense response 50 7.22E-05
Gastric mucosa Regulation of pH 2 0.0530
Monovalent inorganic cation homeostasis 2 0.0677
Bladder Muscle contraction 14 0.0034
Excretion 7 0.0266
Secretion 17 0.0379
Gall bladder Negative regulation of granulocyte differentiation 2 0.0417
Negative regulation of immune system process 3 0.0496
Regulation of granulocyte differentiation 2 0.0519
Medulla oblongata Homophilic cell adhesion 15 8.78E-06
Cell-cell adhesion 18 5.00E-04
Cell adhesion 25 0.0151
Ischiatic nerve Filopodium assembly 5 0.0023
Regulation of action potential in neuron 10 0.0036
Negative regulation of neurogenesis 7 0.0074
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bodies revealed no clear relationship with mRNA expres-
sion levels, although previous studies have reported either
positive correlation with gene expression [12,21] or bell-
shaped correlation patterns [22]. Many genes harbor several
alternative TSSs, which are located throughout the
gene body and yield different splice isoforms. Methy-
lation of such yet unrecognized sites might confound
a correlation analysis of gene body methylation and
gene expression.
Gene expression and methylation in tDMRs
The correlation analysis of tissue-specific methylation with
gene expression was carried out by averaging all of the
CpG beta values within the tDMRs. Collectively, there were
more negative than positive correlation coefficients (63.2%,
2,288 vs. 36.8%, 1,332; Table 4), as expected. In addition,
strongly negative PCCs prevailed over the strongly positive
PCCs (20.7%, 749 vs. 10.3%, 372, respectively) (Fisher’s
exact test, P <2.2 × 10-16).
Our finding of relatively more negative correlations in
the gene bodies (60.9%, 1,148) was slightly unexpected, be-
cause gene body methylation is not usually related to low
expression. However, our finding of a high number of in-
versely correlated CpG sites in CGI-promoter regions
(78.5%, 489) and finding that genes with highly methylated
promoter areas were not highly expressed suggest that
methylation in the promoter area corresponds to gene ex-
pression changes (Additional file 8).
Conclusions
In this study, we analyzed the genome-wide DNA methyla-
tion profiles of human somatic tissues. Although the num-
ber of analyzed individuals was limited, the analysis was
sufficient to provide DNA methylation distribution patterns
across different genomic regions that were largely in agree-
ment with patterns previously observed by similar studies.
Moreover, our results and their validation by external data-
sets revealed a clear correlation between DNA methylation
in the gene promoter areas and the gene expression. Mean-
while, our analysis of methylation in gene bodies did not re-
veal positive [12,21] or bell-shaped [22] correlation patterns
with mRNA expression levels, as it is suggested before.
The methylome data alone was sufficient for correctly dis-
tinguishing, through hierarchical clustering, between all the
17 tissues studied, collectively demonstrating that tissues are
characterized by distinctive methylation patterns that reflect
their tissue-specific functions. We were also able to show that
the variance explained by tissues is much higher than the
variance explained by individuals. As a result of differentially
methylated tissue-specific regions analysis, we identified a
large number of tDMRs, which were enriched for genes that
are closely related to the functions of particular tissue type.
Moreover, hypomethylation, and not hypermethylation, was
more likely to be associated with the tissue-specific functions.
Our study also provoked the question, of how tDMRs
mechanistically contribute to the tissue-specific functions,
especially for the numerous methylation regions that were












Figure 6 Variance explained by the tissues and individuals. Figure is showing the distribution of the R squared statistic obtained for each CpG site. It
is clearly visible, that variance explained by the individuals is insignificant - on average individuals explain only 6.4% of the variance whereas tissues explain 51.2%.
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the methylation in the gene body areas had also high nega-
tive correlation with gene expression suggested that gene
body tDMRs might be important in establishing the
tissue-specific transcription. Still, it remains unclear, how-
ever, how the gene body tDMRs may function as regula-
tors of gene expression, and this question should be
addressed in the future epigenetic studies.
To our knowledge, this study comprehends methyla-
tion data of tissue types that have not been studied yet.
The data are publicly available to the research commu-
nity, as well as the annotated UCSC tracks.
Materials and methods
Ethics statement
The Research Ethics Committee of the University of
Tartu approved the collection of tissue samples for re-
search (permission no 221/M-18). Written informed
consent was obtained from next-of-kin to postmortem
individuals in order to collect the tissue panel during the
autopsy. The research was carried out according to the
World Medical Association Declaration of Helsinki.
Sample collection and DNA preparation
The 17 postmortem human somatic tissues used in this
study were collected at the time of autopsy. All specimens
were subjected to autolysis for 4 to 8 h and then snap-
frozen at -80°C until use in analysis. DNA was extracted
from 25 mg samples of the tissue specimens using the
NucleoSpin® Tissue kit (Macherey-Nagel GmbH, Düren,
Germany). The DNA yield and purity were determined
spectrophotometrically (NanoDrop® ND1000; Thermo Fisher
Scientific Inc., Waltham, MA, USA) and by gel electrophor-
esis, respectively. Bisulfite modification of the genomic DNA
samples (600 ng each) was carried out with the EZ DNA
Methylation™ kit (Zymo Research, Orange, CA, USA) ac-
cording to the manufacturer’s protocol.
Controls for unmethylated and methylated DNA were
represented, respectively, by whole-genome amplified DNA
from subcutaneous adipose tissue (using the GenomiPhi
DNA amplification kit; GE Healthcare, Piscataway, NJ,
USA) and the universal methylated human DNA standard
(Zymo Research). The bisulfite treatment of the control
samples was carried out as described above.
Methylation analysis with illumina infinium
HumanMethylation450 BeadChip
DNA methylation analysis of the total 72 tissue samples
and controls was performed with the Illumina Infinium
HumanMethylation450 BeadChip according to the man-
ufacturer’s standard protocols. This BeadChip contains
Table 3 Gene expression and methylation correlation
Gene region Neg PCCsa Pos PCCsb PCCs < -0.5c PCCs >0.5d Totale
Global 5,710 4,410 1,713 1,090 10,120
56.42% 43.58% 16.93% 10.77%
Promoter + CGI 3,048 2,325 618 567 5,373
56.73% 43.27% 11.50% 10.55%
TSS1500 4,175 4,581 958 1,064 8,756
47.68% 52.32% 10.94% 12.15%
TSS200 4,157 3,199 979 747 7,356
56.51% 43.49% 13.31% 10.15%
5’UTR 1,500 1,604 382 442 3,104
48.32% 51.68% 12.31% 14.24%
1st exon 1,330 1,409 272 357 2,739
48.56% 51.44% 9.93% 13.03%
Body 5,156 4,620 1,573 1,185 9,776
52.74% 47.26% 16.09% 12.12%
3’UTR 3,302 3,494 903 854 6,796
48.59% 51.41% 13.29% 12.57%
Shores 4,534 3,365 1,362 792 7,899
57.40% 42.60% 17.24% 10.03%
Shelves 2,342 2,201 718 576 4,543
51.55% 48.45% 15.80% 12.68%
aNegative Pearson Correlation coefficients (PCCs).
bPositive PCCs.
cStrong negative PCCs, smaller than -0.5.
dStrong positive PCCs, larger than 0.5.
eTotal number of tDMRs in named category.
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more than 485,000 methylation sites, covering 99% of
RefSeq genes with an average of 17 CpGs per gene dis-
tributed across the promoter, 5′-UTR, first exon, gene
body, and 3′-UTR regions [14]. In addition, the Bead-
Chip covers 96% of CGI with an average of five CpG
sites each, as well as the corresponding shores and
shelves. Furthermore, it includes CpGs outside of CGIs,
CGIs outside of coding regions, and micro-RNA pro-
moter regions.
Validation of BeadChip methylation data by Sanger
sequencing
Seventeen genes representing 36 CpG sites (including
three unmethylated and fully methylated sites, and 14
genes with tDMRs) were selected for analysis. Primers
for PCR amplification of the bisulfite-treated DNA
were designed using MethPrimer [23] and are listed in
Additional file 9. The 20 μL reaction mixes contained
80 mM Tris-HCl (pH 9.4 to 9.5), 20 mM (NH4)2SO4,
0.02% Tween-20 PCR buffer, 3 mM MgCl2, 1X Betaine,
0.25 mM dNTP mix, 2 U Smart-Taq Hot DNA polymer-
ase (Naxo, Tartu, Estonia), 50 pmol forward primer, 50
pmol reverse primer, and 20 ng bisulfite-treated genomic
DNA. The PCR cycling conditions were: 15 min at 95°C
for enzyme activation, followed by 17 cycles of 30 s at
95°C, 45 s at 62°C, and 120 s at 72°C, with a final -0.5°C/
cycle step-down gradient over 21 cycles of 30 s at 95°C,
30 s at 52°C, and 120 s at 72°C. The sequencing results were
analyzed with Mutation Surveyor software (Softgenetics,
State College, PA, USA) and the R statistical computing
software [24].
Data normalizing and preprocessing
The raw data were subject to quality control and
normalization using the standard protocols suggested for
the bioconductor R package minfi [25]. All probes con-
taining single nucleotide polymorphisms (n = 65) and
CpG sites from the X (n = 11 232) and Y (n = 416) chro-
mosomes were removed from the analysis, in order to
eliminate the effect of sex-specific methylation.
GO analysis
GO analysis was carried out for the differentially hypo-
methylated and hypermethylated regions between tissues
using DAVID [15,26]). The gene sets that showed hyper-
or hypomethylation were searched against a default
population background (Homo sapiens) and results were
matched with GO biological processes (GOTERM BP-
FAT). The gene sets obtained from tDMR analysis for
each specific tissue were searched against a custom
background, which contained all the genes found by
tDMR analysis.
Correlation analysis of DNA methylation with gene
expression
Gene expression data were obtained from the GEO [27]
and ArrayExpress [28] databases. Eight tissues with data
from the Affymetrix Human Genome U133A Array (HG-


































Figure 7 DNA methylation and gene expression correlation in CGI-promoter regions and the gene body. (A) Correlation analysis of CGI-
promoter methylation and gene expression show that genes with low expression have high methylation. (B) Gene body methylation and gene
expression are not correlated. (A, B) The x-axis shows DNA methylation beta values, and the y-axis shows gene expression values. The different
tissues studied are represented by the following symbols: aortas (•), coronary artery (●), bladder ( ), bone ( ), bone marrows ( ), lymph node ( ),
medulla oblongata (+), and tonsils (×).
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U133A) were selected for analysis; the accession numbers
of the datasets used are listed in Additional file 7. For cor-
relating the global DNA methylation data with gene ex-
pression values, the DNA methylation values were
averaged across the gene. Gene expression data were nor-
malized and preprocessed according to the robust multi-
array average algorithm [29]. All statistical analyses were
performed by R statistical computing software.
Algorithm for identifying tDMRs
An MDL-based method that is similar to the one pro-
posed for finding haplotype blocks was used to identify
differentially methylated regions [30]. In principle, we fit
the same statistical model by moving windows of 1 to 50
probes in width and calculate the description length stat-
istic. Intuitively, when the same model fits well to several
consecutive probes, then one model for all these probes
is less costly, in terms of description length, than several
separate models. Based on the model fit and its descrip-
tion length, the probes were segmented into regions
that, in total, give the MDL.
To identify the tDMRs of the studied tissues, the ana-
lysis of variance (ANOVA) model with an MDL frame-
work was used. For each segment, the model was fitted
to compare the tissue of interest against all other tissues
studied. The tDMRs were identified according to de-
tection by at least three probes and their retaining
statistical significance (P <0.05) after Bonferroni correc-
tion. To help identify regions of realistic length, the
search was conducted only in regions where the distance
between consecutive probes was less than 3 kb. It has
been shown that sequence-specific DNA methylation as
a regulatory mechanism works on regions larger than
1,000 base pairs [31]. Also, it has been suggested that
long-CGI promoters (>2,000 bp) are preferentially asso-
ciated with genes that are important in development and
tissue-specific gene expression [32]. Additional file 10
shows the correlation between methylation beta values
of consecutive probes and how it depends on the dis-
tance between these probes. The conservative choice of
a 3 kb cutoff was based on this distribution of correla-
tions, because for larger distances the average correl-
ation is only 0.18 whereas for shorter distances it is 0.42.
Meanwhile, these blocks are considered as one region
only if the methylation dynamics within the region are
similar enough (in terms of the MDL). Tissues with a
high functional similarity were processed together.
Data access
The data used in this study has been deposited in NCBI’s
Gene Expression Omnibus repository and are accessible
through GEO Series, accession number GSE50192. Also,
the raw data and some extra figures are available on the
website [33].
Table 4 Gene expression and methylation correlation in tDMRs
Gene region Neg PCCsa Pos PCCsb PCCs < -0.5c PCCs >0.5d Totale
Global 2,288 1,332 749 372 3,620
63.2% 36.8% 20.7% 10.3%
Promoter + CGI 489 134 76 37 623
78.5% 21.5% 12.2% 5.9%
5’UTR 264 279 57 77 543
48.6% 51.4% 10.5% 14.2%
1st exon 212 217 41 61 429
49.4% 50.6% 9.6% 14.2%
Body 1,148 737 377 224 1,885
60.9% 39.1% 20.0% 11.9%
3’UTR 190 209 51 62 399
47.6% 52.4% 12.8% 15.5%
Shores 1,275 745 423 202 2,020
63.1% 36.9% 20.9% 10.0%
Shelves 445 269 169 82 714
62.3% 37.7% 23.7% 11.5%
aNegative Pearson Correlation coefficients (PCCs).
bPositive PCCs.
cStrong negative PCCs, smaller than -0.5.
dStrong positive PCCs, larger than 0.5.
eTotal number of tDMRs in named category.
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Additional files
Additional file 1: Methylation validation using Sanger sequencing.
For validation of the methylation data from BeadChip, 17 genes were
chosen, including unmethylated sites (n = 1), fully methylated sites (n = 2),
and genes with tDMRs (n = 14) representing 36 CpG sites altogether. The
x-axis shows DNA methylation beta-values obtained from BeadChip, and
the y-axis shows beta values from Sanger sequencing.
Additional file 2: Global distribution of methylation. The plot
represents the methylation distribution of all specimens (70 samples)
analyzed, as well as the controls of unmethylated (0%, negative control)
and fully methylated (100%, positive control). The global distribution of
methylated CpGs shows that most are either unmethylated or fully
methylated in somatic tissues.
Additional file 3: Description of tDMRs found by the simple linear
model method of best fit according to MDL.
Additional file 4: Variance in tissues explained by gene regions and
CGI regions. (a) The figure is showing the distributions of the R squared
statistic, which describes the variance explained by different gene regions
and intergenic area. It is clear that gene body and intergenic areas are
more variable than gene promoter areas. (b) Distribution of R squared
statistic describes the variance explained by CpG island shores, shelves,
and non-island regions. Figure shows, that CpG islands are the least
variable among these groups.
Additional file 5: GO analysis of hypermethylated tDMRs in specific
tissue types.
Additional file 6: Hierarchical clustering of all the samples studied.
Hierarchical clustering of all the samples studied shows that the similarity
between different tissues was much higher than between individuals, as
tissues are mostly clustering together.
Additional file 7: Gene expression datasets used for correlation
analyses.
Additional file 8: Correlation analysis of tDMRs and gene expression
for methylations in the CGI-promoter and gene body regions. (a)
tDMR genes with low expression show high levels of methylation at
CGI-promoter. (b) Gene body methylation in tDMRs is not correlated with
gene expression. (a, b) The x-axis shows DNA methylation beta values,
and the y-axis shows gene expression values. The different tissues studied
are represented by the following symbols: aorta (•), coronary artery (●),
bladder ( ), bone and joint cartilage ( ), bone marrow ( ), lymph node
( ), medulla oblongata (+), and tonsils (×).
Additional file 9: PCR primers used in the methylation validation
analysis.
Additional file 10: Correlations between consecutive probes. Figure
shows the correlation between methylation beta values of consecutive
probes and how it depends on the distance between these probes.
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